gly

Glyphosate, IARC and politics: ‘We need a more honest debate’

Ian Plewis |
Glyphosate is one of the most hotly-debated herbicides of the modern era. Many of the arguments against the popular weed-killer ...
x Rare Subtypes of Ovarian Cancer

Cancers and other rare diseases in crosshairs of researchers using breakthrough DNA sequencing

Pratik Kirve |
The improvements and discoveries in DNA sequencing in recent years has had immediate clinical consequences, including the real possibility of ...
tumeur emois

Kevin Folta looks back 5 years after release of controversial Séralini GMO rat study

Kevin Folta |
The heavily criticized and retracted paper linked GMO consumption and glyphosate exposure to cancer in rats. The brouhaha that erupted ...
am

Do GMOs, pesticides cause cancer? The Amish would say ‘no’

Andrew Porterfield |
Amish farmers may not get cancer as much, but it's not because they don't use pesticides or GMOs. In fact, ...
cancer

Treating aggressive brain cancer with poliovirus

Ricki Lewis |
The idea of using a modified poliovirus as a treatment for glioblastoma brain cancer isn't new. But recent research shows ...
GettyImages x e

Viewpoint: Activists push glyphosate cancer scare as proxy to limit use of genetically engineered crops

Dan Goldstein |
Monsanto pediatrician and toxicologist Dan Goldstein: As the glyphosate-cancer debate has grown louder, it's become less scientific ...
question

‘We are all mutants’: Why genetic testing struggles to provide answers

Carrie Arnold |
Genetic tests often can help us diagnose disorders and determine risk factors for disease. But uncertainties surrounding genetic mutations makes ...
Screen Shot at AM

Viewpoint: California activists ‘gamed system’ to get glyphosate herbicide labeled as carcinogen

Hank Campbell |
Environmental activists found the perfect targets to help them defame the popular herbicide glyphosate — widely-accepted as safe — in ...
woman

Ignore at your own peril: Race plays role in cancer and other health risks

Alex Berezow |
It may be uncomfortable to discuss, but there are genetic and biological differences among races and genders. Ignoring these factors ...
imgres

Are your food choices killing you?

Andrew Porterfield |
Scientists, the media and policymakers often make glib connections between certain foods, nutrition and disease. The links are a lot ...
immuno

Cancer quest: Can we drive down the cost of promising immunotherapy treatments?

Ian Haydon |
The so-called fourth pillar of cancer therapy still has a major drawback - high cost that make gold appear cheap ...
elephant

Can the evolution of elephants show us how to treat, prevent cancer?

Elephants have had 55 million years to figure out how to resist cancer. An analysis shows that elephants express many ...
Picture

Colon cancer rates spiking among millennials, but no one knows why

Ben Locwin |
It might be tempting for activists to blame GMOs for the rise in colon cancer rates among younger people, but ...
corn

GMO corn that resists cancer-causing aflatoxin showcases biotech’s life-saving potential

Steve Savage |
The creation of GM corn that neutralizes a cancer-causing toxin is a game-changer for human health. The method could be ...
e

Glyphosate found ‘not carcinogenic’: Key European safety agency joins consensus view on herbicide’s safety

Andrew Porterfield |
A key European safety agency says glyphosate does not cause cancer, paving the way for the herbicide to regain long-term ...
glyphosate

Glyphosate: Dangerous chemical or anti-GMO bogeyman?

Tim Barker |
Glyphosate has drawn scrutiny and criticism like no other chemical in agriculture since the controversy over DDT. But years of ...
immune

Fighting cancer by shifting the body’s immune system into overdrive

Meredith Knight |
Gene-targeted treatments and immunotherapy offer great promise to cure cancer, but they work in less than half of patients and ...
white blood cell

Synthetic biologists developing cells programmed to target, destroy cancer

Ben Locwin |
Synthetic biology might be ready to graduate from cells engineered to perform only one task to multiple cells in a ...
Screen Shot at AM

ACLU to Myriad Genetics: Patients, not companies, own personal genetic data

Meredith Knight |
Myriad Genetics is back in another legal dispute. This time it's in hot water for denying patients a portion of ...
bigstock healthcare and medicine concep

It’s not cancer: Removing cancer label from some conditions may greatly improve care

Meredith Knight |
A common thyroid tumor is reclassified as ‘not cancer.’ Will our growing knowledge cancer genetics lead to more reclassifications? ...
Screen Shot at PM

Amish use GMOs, pesticides yet cancer rates remain very low

Andrew Porterfield |
Amish farmers may not get cancer as much, but it's not because they don't use pesticides or GMOs. In fact, ...
zika

Activists behind Zika virus conspiracy theories, Argentine pesticide birth defect scare

Andrew Porterfield |
South America's suffering from a number of epidemics. The worst one may just be misinformation ...
PesticideSpraying

Despite activists’ claims about glyphosate dangers, there’s no cancer spike in Argentina

Andrew Porterfield |
Anti-GMO activists have claimed that cancer rates in farming regions of Argentina have spiked. Interviews with local experts paint a ...
Screen Shot at AM

Why some animals live for centuries and don’t get cancer

David Warmflash |
There are an increasing number of genetic clues from animals that could provide hints to treating aging and age related ...
ovarian cancer cell sem steve gschmeissner

Link between inflammation and cancer

Ben Locwin |
People with chronic inflammatory conditions may be more susceptible to DNA-induced cell mutations which could contribute to getting cancer ...
brain cancer

Ultrasound may help cancer drugs penetrate blood-brain barrier

Ben Locwin |
The blood-brain barrier serves as a major obstacle for treating brain cancers, but several groups are having success forcing the ...
watson

James Watson: Basing ‘war on cancer’ on genome research diverts resources

Andrew Porterfield |
Billions have been spent on the "ultimate weapon" against cancer--gene-based, personalized medicine. But the money may be mis-aimed on the ...